119 related articles for article (PubMed ID: 38825252)
1. ICAM-1 may promote the loss of dopaminergic neurons by regulating inflammation in MPTP-induced Parkinson's disease mouse models.
Zhang F; Pan L; Lian C; Xu Z; Chen H; Lai W; Liang X; Liu Q; Wu H; Wang Y; Zhang P; Zhang G; Liu Z
Brain Res Bull; 2024 Aug; 214():110989. PubMed ID: 38825252
[TBL] [Abstract][Full Text] [Related]
2. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
[TBL] [Abstract][Full Text] [Related]
3. Korean red ginseng suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced inflammation in the substantia nigra and colon.
Jeon H; Bae CH; Lee Y; Kim HY; Kim S
Brain Behav Immun; 2021 May; 94():410-423. PubMed ID: 33662500
[TBL] [Abstract][Full Text] [Related]
4. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
[TBL] [Abstract][Full Text] [Related]
5. Th17 Cells Induce Dopaminergic Neuronal Death via LFA-1/ICAM-1 Interaction in a Mouse Model of Parkinson's Disease.
Liu Z; Huang Y; Cao BB; Qiu YH; Peng YP
Mol Neurobiol; 2017 Dec; 54(10):7762-7776. PubMed ID: 27844285
[TBL] [Abstract][Full Text] [Related]
6. The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration.
Drouin-Ouellet J; Gibrat C; Bousquet M; Calon F; Kriz J; Cicchetti F
J Neuroinflammation; 2011 Oct; 8():137. PubMed ID: 21989292
[TBL] [Abstract][Full Text] [Related]
7. Nigrostriatal Inflammation Is Associated with Nonmotor Symptoms in an Experimental Model of Prodromal Parkinson's Disease.
Oliveira BDS; Toscano ECB; Abreu LKS; Fernandes HB; Amorim RF; Ferreira RN; Machado CA; Carvalho BC; da Silva MCM; de Oliveira ACP; Rachid MA; Rocha NP; Teixeira AL; da Silva ER; de Miranda AS
Neuroscience; 2024 Jun; 549():65-75. PubMed ID: 38750924
[TBL] [Abstract][Full Text] [Related]
8. The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.
Ding YX; Xia Y; Jiao XY; Duan L; Yu J; Wang X; Chen LW
Neurochem Res; 2011 Oct; 36(10):1759-66. PubMed ID: 21562748
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
[TBL] [Abstract][Full Text] [Related]
10. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
11. Alpha-lipoic acid improved motor function in MPTP-induced Parkinsonian mice by reducing neuroinflammation in the nigral and spinal cord.
Zhang J; Wang M; Zhao Y; Zhang Y; Gao Y; Zhang X; Yang G
Neurosci Lett; 2022 Jun; 781():136669. PubMed ID: 35490905
[TBL] [Abstract][Full Text] [Related]
12. Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson's disease.
Li Q; Shen C; Liu Z; Ma Y; Wang J; Dong H; Zhang X; Wang Z; Yu M; Ci L; Sun R; Shen R; Fei J; Huang F
Cell Prolif; 2021 Aug; 54(8):e13094. PubMed ID: 34312932
[TBL] [Abstract][Full Text] [Related]
13. Tinospora cordifolia Suppresses Neuroinflammation in Parkinsonian Mouse Model.
Birla H; Rai SN; Singh SS; Zahra W; Rawat A; Tiwari N; Singh RK; Pathak A; Singh SP
Neuromolecular Med; 2019 Mar; 21(1):42-53. PubMed ID: 30644041
[TBL] [Abstract][Full Text] [Related]
14. Orally Induced High Serum Level of Trimethylamine N-oxide Worsened Glial Reaction and Neuroinflammation on MPTP-Induced Acute Parkinson's Disease Model Mice.
Qiao CM; Quan W; Zhou Y; Niu GY; Hong H; Wu J; Zhao LP; Li T; Cui C; Zhao WJ; Shen YQ
Mol Neurobiol; 2023 Sep; 60(9):5137-5154. PubMed ID: 37266763
[TBL] [Abstract][Full Text] [Related]
15. Genetic suppression of IKK2/NF-κB in astrocytes inhibits neuroinflammation and reduces neuronal loss in the MPTP-Probenecid model of Parkinson's disease.
Kirkley KS; Popichak KA; Hammond SL; Davies C; Hunt L; Tjalkens RB
Neurobiol Dis; 2019 Jul; 127():193-209. PubMed ID: 30818064
[TBL] [Abstract][Full Text] [Related]
16. Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease.
Liu X; Liu S; Tang Y; Pu Z; Xiao H; Gao J; Yin Q; Jia Y; Bai Q
Neurochem Res; 2021 Jun; 46(6):1514-1539. PubMed ID: 33719004
[TBL] [Abstract][Full Text] [Related]
17. Programmed Death-1 Deficiency Aggravates Motor Dysfunction in MPTP Model of Parkinson's Disease by Inducing Microglial Activation and Neuroinflammation in Mice.
Cheng YY; Chen BY; Bian GL; Ding YX; Chen LW
Mol Neurobiol; 2022 Apr; 59(4):2642-2655. PubMed ID: 35142987
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease.
Liang Y; Chen C; Xia B; Wu W; Tang J; Chen Q; Tang L; Yang H; Zhang Z; Lu Y; Yang Y; Zhao Y
Biomed Res Int; 2019; 2019():4379639. PubMed ID: 30834264
[TBL] [Abstract][Full Text] [Related]
19. Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.
Fan Z; Liang Z; Yang H; Pan Y; Zheng Y; Wang X
J Neuroinflammation; 2017 Dec; 14(1):256. PubMed ID: 29262843
[TBL] [Abstract][Full Text] [Related]
20. Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson's disease model.
Gao MR; Wang M; Jia YY; Tian DD; Liu A; Wang WJ; Yang L; Chen JY; Yang Q; Liu R; Wu YM
Brain Res Bull; 2020 Nov; 164():55-64. PubMed ID: 32846198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]